DESONIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Desonide, and when can generic versions of Desonide launch?
Desonide is a drug marketed by Alembic, Cadila, Cosette, Glenmark Speclt, Padagis Us, Taro, Cintex Svcs, Fougera Pharms, Pai Holdings Pharm, Encube Ethicals, Glenmark Pharms Ltd, and Hikma. and is included in twenty NDAs.
The generic ingredient in DESONIDE is desonide. There are thirty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desonide
A generic version of DESONIDE was approved as desonide by TARO on August 3rd, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DESONIDE?
- What are the global sales for DESONIDE?
- What is Average Wholesale Price for DESONIDE?
Summary for DESONIDE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 20 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 8 |
| Patent Applications: | 4,822 |
| Drug Prices: | Drug price information for DESONIDE |
| Drug Sales Revenues: | Drug sales revenues for DESONIDE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DESONIDE |
| What excipients (inactive ingredients) are in DESONIDE? | DESONIDE excipients list |
| DailyMed Link: | DESONIDE at DailyMed |
Recent Clinical Trials for DESONIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Procter and Gamble | Phase 3 |
| EMS | Phase 4 |
| NeoStrata Company, Inc. | Phase 3 |
Pharmacology for DESONIDE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for DESONIDE
Anatomical Therapeutic Chemical (ATC) Classes for DESONIDE
US Patents and Regulatory Information for DESONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | DESONIDE | desonide | CREAM;TOPICAL | 214396-001 | Dec 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Padagis Us | DESONIDE | desonide | OINTMENT;TOPICAL | 017426-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cintex Svcs | DESONIDE | desonide | GEL;TOPICAL | 202470-001 | May 11, 2020 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Speclt | DESONIDE | desonide | CREAM;TOPICAL | 209729-001 | Jul 24, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | DESONIDE | desonide | LOTION;TOPICAL | 202161-001 | Oct 31, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | DESONIDE | desonide | OINTMENT;TOPICAL | 074254-001 | Aug 3, 1994 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | DESONIDE | desonide | LOTION;TOPICAL | 213632-001 | Aug 24, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
